Assessing risk factors and prognosis for aortic valve diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter cohort study focuses on patients diagnosed with aortic valve disease, including aortic insufficiency and aortic stenosis, during hospitalization. The study aims to evaluate prognostic risk factors and construct a predictive model to guide clinical decision-making. By following patients over time, the study will assess all-cause mortality and cardiovascular events as primary and secondary outcomes, respectively.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age ≥ 18
* diagnosed as aortic valve disease

Exclusion Criteria:

* aortic valve replacement at baseline

Where it's running

• First Affiliated Hospital, Sun Yat-Sen University
  Guangzhou, Guangdong, China Recruiting
• Third Affiliated Hospital, Sun Yat-Sun University
  Guangzhou, Guangdong, China Recruiting
• Jieyang People's Hospital
  Jieyang, Guangdong, China Recruiting
• Second Affiliated Hospital of Shantou University Medical College
  Shantou, Guangdong, China Recruiting
• Eighth Affiliated Hospital, Sun Yat-Sen University
  Shenzhen, Guangdong, China Recruiting
• Affiliated Hospital of Guangdong Medical University
  Zhanjiang, Guangdong, China Recruiting

Study contacts

• Principal investigator: xiaodong zhuang, PhD — First Affiliated Hospital, Sun Yat-Sen University
• Study coordinator: xiaodong zhuang, PhD
• Email: zhuangxd3@mail.sysu.edu.cn
• Phone: +86 13760755035

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• KONECT RESILIA Aortic Valved Conduit real-world use in adults needing valve and ascending aorta replacement

  This study tests how the KONECT RESILIA aortic valved conduit performs in adults needing aortic valve and ascending aorta replacement.

  Recruiting at 3 sites Edwards Lifesciences · München, Bavaria and 2 other locations · NCT07619872

• Savvywire versus standard LV guidewires during transfemoral TAVI

  For people 50 and older having transfemoral TAVI, researchers will compare the Savvywire and standard LV guidewires to see if the Savvywire improves pacing and procedure-related blood flow.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07366671

• EmStop Embolic Protection System for TAVR in Aortic Valve Stenosis

  This study tests whether the EmStop protective device can safely capture and remove debris during transcatheter aortic valve replacement in adults with severe aortic valve stenosis.

  Recruiting at 7 sites EmStop Inc · Thousand Oaks, California and 6 other locations · NCT07276711

• Tracking progression and consequences of heart valve disease

  This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.

  Recruiting at 15 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Fuzhou, Fujian and 14 other locations · NCT07267117

• Real-world outcomes of the INSPIRIS RESILIA aortic valve in adults

  This registry will collect real-world data to see how the INSPIRIS RESILIA aortic valve performs in adults undergoing aortic valve replacement.

  Recruiting at 15 sites Edwards Lifesciences · Heidelberg, Baden-Wurttemberg and 14 other locations · NCT07120048

• Transcatheter JenaValve or J-Valve treatment for severe aortic regurgitation

  This project will try two transcatheter heart valves (JenaValve and J-Valve) to treat people with severe symptomatic aortic regurgitation who are high risk for open-heart surgery.

  Recruiting Prince of Wales Hospital, Shatin, Hong Kong · Hong Kong, Shatin · NCT07021612

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.